TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

DGFT told to curb export of 12 drug ingredients

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, February 19

Advertisement

The Department of Pharmaceuticals has asked the Directorate General of Foreign Trade (DGFT) to issue orders restricting export of 12 active pharmaceutical ingredients (APIs) and formulations in the wake of the coronavirus outbreak.

Advertisement

A high-level committee formed by the Department of Pharmaceuticals to monitor supply of raw materials for drugs from China has recommended restrictions on export of these items. The 12 APIs and formulations include antibiotics such as choramphenicol,neomycin, metronidazole and vitamins B1, B12, B6 along with progesterone. — PTI

Advertisement
Show comments
Advertisement